Cases & Deals

  • Home
  • Practices
  • Sanofi defends proposed class action alleging improper Orange Book listings and sham patent litigation

Share

Sanofi defends proposed class action alleging improper Orange Book listings and sham patent litigation

February 2020

Client(s) Sanofi-Aventis U.S. LLC

Jones Day is defending Sanofi-Aventis U.S. LLC against a proposed class action alleging that Sanofi improperly listed certain patents in the FDA's Orange Book and engaged in sham patent litigation to forestall competition for its diabetes drug, Lantus.

In re Lantus Direct Purchaser Antitrust Litigation, No. 16-cv-12652 (D. Mass.); No. 18-02086 (1st Cir.)

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.